
Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis …
2020年10月10日 · Rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) is a hereditary degenerative disorder in which mutations in the gene encoding RHO, the light-sensitive G protein-coupled receptor involved in phototransduction in rods, lead to progressive loss of rods and subsequently cones in the retina.
Allele-specific gene-editing approach for vision loss ... - eLife
2023年6月5日 · Mutant RHO is the most frequent genetic cause of autosomal dominant retinitis pigmentosa (adRP). Here, we developed an allele-specific gene-editing therapeutic drug to selectively target the human T17M RHO mutant allele while leaving the wild-type RHO allele intact for the first time.
Gene Augmentation for adRP Mutations in RHO - PMC
Experiments in autosomal dominant retinitis pigmentosa (adRP) mouse models suggest that both RHO augmentation and supplementation plus suppression preserve the survival of rod cells. Mutations in the rhodopsin (RHO) gene cause rod photoreceptor cells to die.
Disease modeling and pharmacological rescue of autosomal …
2024年4月25日 · Mutations in the rhodopsin gene (RHO) account for ~25% cases of autosomal dominant RP (adRP). In this study, we describe the disease characteristics of the first-ever reported mono-allelic copy number variation (CNV) in RHO as a novel cause of adRP.
Mutation-independent gene knock-in therapy targeting 5′UTR for ...
2023年3月8日 · RHO mutations are responsible for 20–30% of adRP, with the RhoP23H (p.Pro23His, c.68 C > A) mutation being the most common mutation in adRP patients. 2, 3 Here we present a...
细数RHO:视网膜色素变性研究下的热门基因(内含小鼠模型推 …
EDIT-103是一种不依赖于突变的基于CRISPR/Cas9的基因编辑疗法,使用双AAV5载体递送来敲除和替换视紫红质基因中的突变,以保持感光器功能,可通过视网膜下注射给药。 该疗法有望解决150多种可导致RHO adRP病的RHO功能获得型的突变。
Mirtron-mediated RNA knockdown/replacement therapy for the
2021年8月16日 · Rhodopsin (RHO) gene mutations are a common cause of autosomal dominant retinitis pigmentosa (ADRP). The need to suppress toxic protein expression together with mutational heterogeneity pose...
Modeling autosomal dominant retinitis pigmentosa by using …
2024年4月1日 · Rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) causes progressive vision loss and is potentially incurable, accounting for 25% of adRP cases. Studies on RHO-adRP mechanism were at large based on the biochemical and cellular properties, especially class-3.
Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa
2020年10月7日 · Rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) is a hereditary degenerative disorder in which mutations in the gene encoding RHO, the light-sensitive G protein-coupled receptor involved in phototransduction in rods, lead to progressive loss of rods and subsequently cones in the retina.
Rhodopsin-associated retinal dystrophy: Disease mechanisms and ...
2023年4月2日 · Mutations in the rhodopsin-encoding gene RHO are the leading cause of autosomal dominant retinitis pigmentosa (ADRP). To date, more than 200 mutations have been identified in RHO. The high allelic heterogeneity of RHO mutations suggests complicated pathogenic mechanisms.